Pharmacological Treatment
Low-Dose Atropine Eye Drops
A simple nightly eye drop, backed by major international trials, that slows myopia progression through a mechanism entirely different to our optical treatments.
A simple nightly eye drop, backed by major international trials, that slows myopia progression through a mechanism entirely different to our optical treatments.
Atropine has been used in eye care for well over a century, but its role in myopia control is a more recent, and now very well-studied, development. At low doses, typically between 0.01% and 0.05%, a single drop instilled each night appears to influence receptors involved in regulating how the eye grows, slowing the axial elongation behind progressing myopia.
Unlike our optical treatments, atropine involves no lens wear at all, offering families a genuinely different pathway to the same goal.
The right atropine concentration balances effectiveness against side effects, and we set it individually for every child.
From 0.01% up to 0.05%, spanning the doses studied in major international trials.
Higher low-dose concentrations generally slow progression more, with a corresponding rise in side effects.
Starting dose and any adjustment over time are based on your child's progression, response and tolerance.
A simple bedtime routine addition, no daytime dosing or lens handling required.
ATOM2 and LAMP are among the largest, longest-running randomised trials in myopia control.
Low-dose atropine's evidence base includes some of the largest, longest-running randomised controlled trials in myopia control.
A single drop of low-dose atropine, in the eye or eyes being treated, fits easily into an existing bedtime routine.
At low doses, atropine appears to act on receptors within the eye involved in regulating axial elongation, though the exact mechanism isn't fully understood.
Major trials including ATOM2 and LAMP confirm meaningfully slowed progression compared with placebo, with a clear dose-response relationship.
Some of the largest, longest-running randomised trials in myopia control.
A single drop before bed, no lens handling or daily insertion.
Concentration is set and adjusted specifically for your child's response.
Works alongside, or independently of, our optical treatment options.
Atropine has been used in eye care for well over a century.
Regular reviews track response and manage any side effects.
We use low-dose atropine as a first-line or combination treatment, prescribed individually and monitored closely.
We assess progression rate, ocular health and suitability, and establish a baseline axial length measurement.
Our optometrist selects a starting concentration based on your child's specific progression and circumstances.
We review regularly, tracking axial length, prescription and side effects, adjusting the dose as needed.
Book a comprehensive myopia assessment and we'll talk through low-dose atropine and how it compares with our other treatment options for your child specifically.
Individual results and appropriate dosing vary by child. This page is general information, not medical advice, please speak with one of our optometrists about whether atropine is suitable for your child.